Literature DB >> 21251639

Late restenosis following sirolimus-eluting stent implantation.

Nehiro Kuriyama1, Yoshio Kobayashi, Tatsuya Nakama, Daigo Mine, Kensaku Nishihira, Mitsuhiro Shimomura, Katsumasa Nomura, Keiichi Ashikaga, Akihiko Matsuyama, Yoshisato Shibata.   

Abstract

OBJECTIVES: This serial angiographic study evaluated the incidence and predictors of late restenosis after sirolimus-eluting stent (SES) implantation.
BACKGROUND: Previous studies showed late restenosis (i.e., late catch-up phenomenon) after implantation of 7-hexanoyltaxol-eluting stents and nonpolymeric, paclitaxel-eluting stents.
METHODS: Between August 2004 and December 2006, SES implantation was performed in 1,393 patients with 2,008 lesions, in whom 8-month and 2-year follow-up coronary angiography were planned.
RESULTS: Of 2,008 lesions, 1,659 (83%) underwent 8-month follow-up angiography (8.3 ± 2.2 months). Restenosis was observed in 122 lesions (7.4%). Coronary angiography 2 years (1.9 ± 0.4 years) after SES deployment was performed in 1,168 lesions (74% of lesions without restenosis at 8-month follow-up angiography). Late restenosis was observed in 83 lesions (7.1%). There was significant decrease in minimum luminal diameter (MLD) between 8-month and 2-year follow-up (2.56 ± 0.56 mm vs. 2.35 ± 0.71 mm, p < 0.001). Multivariate analysis showed in-stent restenosis before SES implantation and MLD at 8-month follow-up as independent predictors of late restenosis.
CONCLUSIONS: Between 8-month and 2-year follow-up after SES implantation, MLD decreases, which results in late restenosis in some lesions. In-stent restenosis before SES implantation and MLD at 8-month follow-up are independent predictors of late restenosis.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251639     DOI: 10.1016/j.jcin.2010.09.013

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  7 in total

Review 1.  Choosing the right coronary stent in the modern era.

Authors:  Bora Toklu; Sripal Bangalore
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

2.  Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography.

Authors:  Rodolfo Staico; Marco A Costa; Daniel Chamié; Hiram Bezerra; Luciana V Armaganijan; Ricardo A Costa; José Ribamar Costa; Dimytri Siqueira; Marinella Centemero; Áurea Chaves; Luiz Fernando Tanajura; Alexandre Abizaid; Fausto Feres; J Eduardo M R Sousa; Amanda G M R Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2013-03-03       Impact factor: 2.357

3.  Constructing bio-layer of heparin and type IV collagen on titanium surface for improving its endothelialization and blood compatibility.

Authors:  Kun Zhang; Jun-ying Chen; Wei Qin; Jing-an Li; Fang-xia Guan; Nan Huang
Journal:  J Mater Sci Mater Med       Date:  2016-03-02       Impact factor: 3.896

4.  Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial.

Authors:  In Ho Chae; Chang Hwan Yoon; Jin Joo Park; Il Young Oh; Jung Won Suh; Young Seok Cho; Tae Jin Youn; Dong Ju Choi
Journal:  J Korean Med Sci       Date:  2017-06       Impact factor: 2.153

5.  Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial.

Authors:  Sang-Don Park; Chang-Hwan Yoon; Il-Young Oh; Jung-Won Suh; Young-Suk Cho; Tae-Jin Youn; Dong-Ju Choi; In-Ho Chae
Journal:  Trials       Date:  2013-02-08       Impact factor: 2.279

6.  Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.

Authors:  Yuhei Nojima; Yoshinori Yasuoka; Kiyoshi Kume; Hidenori Adachi; Susumu Hattori; Ryo Matsutera; Yasuaki Kohama; Tatsuya Sasaki
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

7.  Influence of Late Vascular Inflammation on Long-Term Outcomes Among Patients Undergoing Implantation of Drug Eluting Stents: Role of C-Reactive Protein.

Authors:  Masanori Shiba; Hideki Itaya; Raisuke Iijima; Masato Nakamura
Journal:  J Am Heart Assoc       Date:  2016-09-24       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.